Related Articles
Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody
miR‑200b inhibits CD133+ glioma cells by targeting the AKT pathway
Gene expression of growth signaling pathways is up-regulated in CD133-positive medulloblastoma cells
The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics
The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer